期刊文献+

凋亡抑制因子Survivin基因的克隆及其在Pichia pastoris中的表达 被引量:1

Cloning of survivin-an inhibitor of apoptosis proteins and expressed in pichia pastoris system
原文传递
导出
摘要 目的克隆凋亡抑制因子Survivin基因,利用甲醇酵母Pichiapastoris真核表达系统表达Survivin蛋白。方法利用Survivin特异引物,通过PCR方法扩增人Survivin基因后进行测序,将序列正确的Survivin基因与分泌表达载体pPic9k重组,重组体酶切线性化后用电穿孔法转入酵母宿主菌GS115/His-中,以不同浓度G418/YPD平板筛选,经PCR扩增鉴定阳性克隆,再用含1%甲醇的培养基BMMY诱导表达蛋白,ELISA法检测表达产物。结果克隆的人Survivin基因与GenBank中的Survivin基因序列完全一致,无突变;构建了真核表达载体pPic9k-Survivin,并转入酵母菌GS115/His-后,筛选出了抗高浓度(4mg/mL)G418的阳性克隆(GS115/His+)6个,并用PCR法进行了鉴定;Survivin的表达量与时间有关,48h的表达量最高。结论用Pichiapastoris真核表达系统表达Survivin蛋白的方法可行,若进一步优化条件,可大量表达Survivin蛋白,为进一步研究Survivin的生物学功能及其在肿瘤发生发展中的作用提供了重要的实验基础。 Objective To clone human survivin gene and express survivin-an inhibitor of apoptosis proteins in Pichia pastoris eukaryotic expression system. Methods Full length survivin gene was amplified by PCR using survivin specific primers. The verified survivin gene by sequencing was subcloned into pPic9k. The recombinant plasmid was linearized by restriction enzyme cutting. The linear survivin gene was introduced into GSllS/His^- cells by electroporation. The transformants were transferred onto YPD plates that contained different concentrations of G418 for screening the positive clones. The integrated survivin gene in positive clones was confirmed by PCR. Selected transformants were cultured in BMMY medium with 1% methanol for inducing the expression of survivin protein. The expressed survivin protein was analyzed by ELISA. Results The cloned human survivin sequence was the same as that in the GeneBank. The recombinant pPic9k-survivin was constructed in Picha pastoris eukaryotic expression vector. After the linear digestion, the recombinant vector was introduced into GS115/His^-cells, the 6 positive clones against G418 (4 mg/mL) were obtained and confirmed by PCR; the highest survivin protein was expressed when expressed for two days in 1% methanol BMMY medium. Conclusions Improved survivin protein yield may be reached by modifying the experimental conditions. This will help to further study the biological functions of survivin and its roles in tumor developments.
出处 《肿瘤研究与临床》 CAS 2005年第5期305-308,共4页 Cancer Research and Clinic
基金 北京市肿瘤分子生物学高技术实验室基金资助项目(953850500)
关键词 SURVIVIN 凋亡抑制 PICHIA pastoris表达 肿瘤 Survivin Apoptosis inhibitor Piehia pastoris expression Tumor
  • 相关文献

参考文献8

  • 1Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma[J]. Nat Med, 1997, 3(8):917-921.
  • 2Islam A, Kageyama H, Takada N, et al. High expression of Survivin,mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma[J]. Oncogene,2000, 19(5): 617-623.
  • 3Mesri M, Morales-Ruiz M, Ackermann E J, et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting[J]. Am J Pathol, 2001, 158(5): 1757-1765.
  • 4Li F, Ambrosini G, Chu E Y, et al. Control of apoptosis and mitotic spindle checkpoint by survivin[J]. Nature, 1998, 396(6711): 580-584.
  • 5Fortugno P, Wall N R, Giodini A, et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function[J]. J Cell Sci, 2002, 163(1):109-116.
  • 6Smith S D, Wheeler M A, Plescia J, et al. Urine detection of survivin and diagnosis of bladder cancer[J]. JAMA, 2001, 285(3): 324-328.
  • 7Monzo M, Rosell R, Felip E, et al. A novel anti- apoptosis gene: Reexpression of survivin messenger RNA as a prognosis marker in nonsmall-cell lung cancers[J]. J Clin Oncol, 1999, 17(7): 2100-2104.
  • 8Okada E, Murai Y, Matsuik K, et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients [J]. Cancer Lett, 2001, 163(1): 109-116.

同被引文献18

  • 1程琪辉,孙淑华,麦羡霞,李新爱.恶性肿瘤患者血清VEGF的检测及临床意义[J].肿瘤研究与临床,2005,17(3):180-182. 被引量:17
  • 2陈俊强,陈明强,李云英,朱坤寿,潘建基,林宇,邵凌东,佘志廉,陈燕.食管癌患者血清中组织多肽特异抗原的表达及临床意义[J].肿瘤研究与临床,2005,17(5):313-314. 被引量:2
  • 3刘俊,吕长兴,王家明.同步放化疗治疗不能手术的食管癌临床结果[J].中华放射肿瘤学杂志,2006,15(3):185-187. 被引量:89
  • 4Wiedmann MW,M(o)ssoner J.New and emerging combination therapies for esophageal cancer[J].Cancer Manag Res,2013,5:133-146.
  • 5Urba SG,Orringer MB,Ianettonni M,et al.Concurrent cisplatin,paclitaxel and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma[J].Cancer,2003,98:2177-2183.
  • 6Day FL,Leong T,Ngan S,et al.Phase I trial of docetaxuel,cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer[J].Br J Cancer,2011,104:265-271.
  • 7Khushalani NI,Leichman CG,Proulx G,et al.Oxaliplatin in combination with protracted-infushion fluorouracil and radiation:report of a clinical trail for patients with esophageal cancer[J].J Clin Oncol,2002,20:2844-2850.
  • 8Siewert JR,Stein H J,Feith M,et al.Histologic tumor type is an independent prognostic parameter in esophageal cancer:lessons from more than 1 000 consecutive resections at a single center in the Western world[J].Ann Surg,2001,234:360-369.
  • 9Kawashima M,Ikeda H,Yorozu A,et al.Clinical features of esophageal cancer in the octogenarian treated by definitive radiotherapy:a multi-institutional retrospective survey[J].Jpn J Clin Oncol,1998,28,301-307.
  • 10ParkJW,KimJH,ChoiEK,etal.Prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy[J].Int J Radiat Oncol Biol Phys,2011,81:691-697.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部